NPC
HAE icon

National Planning Corporation’s Haemonetics HAE Stock Holding History

National Planning Corporation’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-900
Closed -$33.8K – 1244
2014
Q4 		$33.8K Buy
+900
New +$33K ﹤0.01% 1465

Other funds holding HAE

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

National Planning Corporation's HAE Position: Q1 2015 in Review

National Planning Corporation sold out of Haemonetics (HAE) in Q1 2015, closing a stake of 900 shares — an estimated $33.8K sold.

National Planning Corporation first reported a position in HAE in Q4 2014 and held it in 1 quarter. The position peaked at $33.8K in Q4 2014. 169 funds tracked by Wall St. Rank hold HAE as of Q1 2015.

  • National Planning Corporation reported no remaining Haemonetics position as of Q1 2015 after selling out during the quarter.
  • National Planning Corporation sold 900 Haemonetics shares in Q1 2015, an estimated $33.8K.
  • National Planning Corporation first reported a position in Haemonetics in Q4 2014 and held it in 1 quarter.
  • National Planning Corporation's Haemonetics position peaked at $33.8K in Q4 2014.
  • 169 funds tracked by Wall St. Rank held Haemonetics as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.